Mission Creek Capital Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-2,808
| Closed | -$1.46M | – | 237 |
|
2024
Q3 | $1.46M | Buy |
2,808
+99
| +4% | +$51.5K | 0.34% | 89 |
|
2024
Q2 | $1.47M | Buy |
2,709
+1,397
| +106% | +$757K | 0.37% | 79 |
|
2024
Q1 | $680K | Buy |
1,312
+470
| +56% | +$244K | 0.18% | 134 |
|
2023
Q4 | $397K | Sell |
842
-25
| -3% | -$11.8K | 0.1% | 167 |
|
2023
Q3 | $377K | Sell |
867
-14
| -2% | -$6.09K | 0.13% | 164 |
|
2023
Q2 | $392K | Sell |
881
-43
| -5% | -$19.1K | 0.13% | 169 |
|
2023
Q1 | $425K | Sell |
924
-507
| -35% | -$233K | 0.14% | 162 |
|
2022
Q4 | $734K | Sell |
1,431
-65
| -4% | -$33.3K | 0.26% | 114 |
|
2022
Q3 | $679K | Buy |
1,496
+1
| +0.1% | +$454 | 0.26% | 114 |
|
2022
Q2 | $722K | Sell |
1,495
-10
| -0.7% | -$4.83K | 0.24% | 119 |
|
2022
Q1 | $739K | Sell |
1,505
-5
| -0.3% | -$2.46K | 0.2% | 139 |
|
2021
Q4 | $700K | Buy |
1,510
+1
| +0.1% | +$464 | 0.14% | 150 |
|
2021
Q3 | $563K | Sell |
1,509
-100
| -6% | -$37.3K | 0.1% | 165 |
|
2021
Q2 | $614K | Sell |
1,609
-40
| -2% | -$15.3K | 0.1% | 143 |
|
2021
Q1 | $592K | Sell |
1,649
-75
| -4% | -$26.9K | 0.09% | 145 |
|
2020
Q4 | $554K | Hold |
1,724
| – | – | 0.17% | 135 |
|
2020
Q3 | $463K | Sell |
1,724
-132
| -7% | -$35.5K | 0.18% | 137 |
|
2020
Q2 | $488K | Buy |
1,856
+11
| +0.6% | +$2.89K | 0.26% | 96 |
|
2020
Q1 | $419K | Sell |
1,845
-80
| -4% | -$18.2K | 0.23% | 99 |
|
2019
Q4 | $581K | Buy |
+1,925
| New | +$581K | 0.27% | 99 |
|